Current Alzheimer's drugs (aduhelm, lecanemab) show minimal slowing of cognitive decline, and recent data suggests they cause significant brain shrinkage compared to untreated disease controls, yet this data was not disclosed by researchers.
factualpending
Speaker
Dr. David PerlmutterEvidence Quote
“it has a minimal effect in terms of slowing cognitive decline. People still decline cognitively. And new news, uh I'll do a podcast on this uh as of 3 days ago, it looks as if the data that looked at the follow-up brain scans on people treated with these types of drugs shows significant shrinkage uh of the brain in comparison to controls”
Source
Oral Bacteria And Your Health - with Dr. Mark Burhenne | The Empowering Neurologist EP. 162— DavidPerlmutterMDCreated: 8/12/2026, 6:27:27 PM
Your notes
Loading notes...